Honasa Consumer Limited (HONASA)
Press Release on the unaudited financial results for the quarter ended June 30, 2026
Press Release - Q1FY27
- Revenue 785 Cr +31.8% y-y; EBITDA 110 Cr more than doubled; PAT 90 Cr with 11.5% margin
- Focus Categories grew 35%+, driven by General Trade, Modern Trade and eCommerce
- Mamaearth grew high-teens; Rice Dewy Bright #1 face cleanser; Rosemary shampoo 100 Cr+ ARR
- The Derma Co. crossed 1,000 Cr NSV ARR and entered teens EBITDA club
- Younger Brands grew 40%+, BTM Ventures crossed 150 Cr ARR, expanding beyond South India
- Offline channels scaled with 40%+ growth in General and Modern Trade; 3 lakh outlets covered
- Entered fragrance category with FIKN, India's first elixir brand in a large underpenetrated market
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 HONASA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add HONASA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Honasa Consumer Limited
Important.
The summary above is generated automatically from Honasa Consumer Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.